These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25842594)

  • 21. Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town.
    Haque M; Emerson SH; Dennison CR; Navsa M; Levitt NS
    S Afr Med J; 2005 Oct; 95(10):798-802. PubMed ID: 16341336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Provider organization performance assessment utilizing diabetes physician recognition program.
    Wall B; Chiao E; Plauschinat CA; Miner PA; Jackson JH; Humphrey B
    Am J Manag Care; 2009 Feb; 15(2):132-6. PubMed ID: 19284810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy.
    Rakel RE
    Adv Ther; 2009 Sep; 26(9):838-46. PubMed ID: 19768641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Insulin and diabetes control in Argentina].
    Gagliardino JJ; Costa Gil JE; Faingold MC; Litwak L; Fuente GV
    Medicina (B Aires); 2013; 73(6):520-8. PubMed ID: 24356260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stepping up: a nurse-led model of care for insulin initiation for people with type 2 diabetes.
    Furler JS; Blackberry ID; Walker C; Manski-Nankervis JA; Anderson J; O'Neal D; Young D; Best J
    Fam Pract; 2014 Jun; 31(3):349-56. PubMed ID: 24473676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
    Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
    Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The increase in the use of drug treatment for diabetes mellitus in the Netherlands, 1998-2003].
    Langendam MW; Hooijkaas C; Piepenbrink JF
    Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1396-401. PubMed ID: 16841589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin and oral hypoglycemic agents.
    Price MJ
    Nurs Clin North Am; 1983 Dec; 18(4):687-706. PubMed ID: 6359069
    [No Abstract]   [Full Text] [Related]  

  • 29. Consensus on Bridges for Barriers to Insulin Therapy.
    Kalra S; Ghosal S; Shah P
    J Assoc Physicians India; 2017 Mar; 65(3 Suppl):23-30. PubMed ID: 28832101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of gestational diabetes by physicians in Turkey.
    Akinci B; Tosun P; Bekci E; Yener S; Demir T; Yesil S
    Prim Care Diabetes; 2010 Oct; 4(3):173-80. PubMed ID: 20558123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unlocking the opportunity of tight glycaemic control. Far from goal.
    Del Prato S
    Diabetes Obes Metab; 2005 Nov; 7 Suppl 1():S1-4. PubMed ID: 16135133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug therapy for diabetes.
    Haas LB
    Nurse Pract Forum; 1991 Sep; 2(3):166-74. PubMed ID: 1840969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.
    Darmon P; Curtillet C; Boullu S; Laugier A; Dutour A; Oliver C
    Diabetes Care; 1998 Sep; 21(9):1575. PubMed ID: 9727917
    [No Abstract]   [Full Text] [Related]  

  • 34. Barriers to insulin initiation and intensification and how to overcome them.
    Kunt T; Snoek FJ
    Int J Clin Pract Suppl; 2009 Oct; (164):6-10. PubMed ID: 19751453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Could clinical inertia in part explain the unexpected association of insulin therapy with poorer cardiovascular outcomes in observational studies on diabetes?
    Giorda CB
    Diabetes Res Clin Pract; 2011 Jun; 92(3):e47-8. PubMed ID: 21035888
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapeutic education and continuous glucose monitoring in insulin-treated diabetic patients].
    Thielen V; Radermecker RP; Renard E; Bringer J; Scheen AJ
    Rev Med Suisse; 2010 Sep; 6(260):1596-600. PubMed ID: 20853714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical services for patients with diabetes. Module 3. Current concepts in diabetes therapy.
    Am Pharm; 1986 Apr; NS26(4):suppl 1-12. PubMed ID: 3518380
    [No Abstract]   [Full Text] [Related]  

  • 38. [Insulin pens for treatment of diabetes].
    Bärtsch U; Comtesse Ch; Wetekam B
    Ther Umsch; 2006 Jun; 63(6):398-404. PubMed ID: 16841576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of diabetes mellitus.
    Duncan TG
    W V Med J; 1967 Aug; 63(8):233-9. PubMed ID: 5233012
    [No Abstract]   [Full Text] [Related]  

  • 40. Prescription pattern of antidiabetic drugs in the outpatient departments of hospitals in Malappuram district, Kerala.
    Shamna M; Karthikeyan M
    J Basic Clin Physiol Pharmacol; 2011 Sep; 22(4):141-3. PubMed ID: 22865436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.